Related Experiment Videos
Interactions of anabolic steroids
1Institute of Experimental and Clinical Pharmacology, Karl Franzens-University, Graz, Austria.
Wiener Medizinische Wochenschrift (1946)
|January 1, 1993
Summary
Anabolic-androgenic steroids can have beneficial interactions with cancer therapies, improving patient outcomes. However, they may increase sensitivity to anticoagulants and antidiabetic drugs, requiring careful patient monitoring.
Area of Science:
- Pharmacology
- Oncology
- Endocrinology
Background:
- Drug-drug interactions are complex and difficult to predict.
- Established interactions exist for anabolic-androgenic steroids (AAS).
- AAS have known therapeutic and adverse interaction profiles.
Purpose of the Study:
- To outline the established interactions of anabolic-androgenic steroids.
- To highlight beneficial interactions with radiotherapy and cytostatic drugs.
- To identify potentially adverse interactions with other medications.
Main Methods:
- Review of established drug interactions involving anabolic-androgenic steroids.
- Analysis of therapeutic benefits in combination with cancer treatments.
- Identification of potential adverse effects with concurrent medications.
Main Results:
- Anabolic steroids show therapeutic benefits when used with radiotherapy and cytostatic drugs.
- These benefits include preventing hematopoietic depression and reducing protein catabolism.
- Increased sensitivity to oral anticoagulants and antidiabetic drugs is a potential adverse interaction.
Conclusions:
- Adjuvant anabolic compounds can improve patient condition during cancer therapy.
- Careful monitoring is essential for patients on anabolic steroids with oral anticoagulants or antidiabetic drugs.